Close

CSM To Host A Live Webinar On Direct-To-Patient Shipping For Clinical Trials

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

FDA Approval of AMVUTTRA for ATTR Amyloidosis

Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics,...

Rina-S Shows Promise in Advanced Ovarian Cancer

Genmab has reported encouraging findings from the Phase 2...

New Data Shows Gazyva’s Superiority in Lupus Nephritis

The New England Journal of Medicine has published detailed...

CSM, a leading provider of clinical trial supply services, will conduct an upcoming webinar, “Discover How Direct-to-Patient Shipping is Changing Clinical Trials.”

This webinar, hosted by FierceMarkets, will explore how sponsor companies and CROs are adopting direct-to-patient supply chain strategies to reach and treat patients in new, innovative, and effective ways. This presentation is free to the public and will take place on Wednesday, September 28th, 2:00PM Eastern. 

The webinar will cover a comprehensive case study where multiple providers worked together on designing and implementing a direct-to-patient distribution strategy for complex clinical trials. Participants will learn how to strategically design direct-to-patient trials, reach wider patient populations, perform complex clinical trials, and increase patient enrollment and retention rates. Visit this registration page for important information regarding the webinar: http://bit.ly/2b9YuuS .

Moderating the session is Eric Sagonowsky, Associate Editor on the FierceMarkets Life Sciences team. Speaking on the topic of supply chain strategy and logistics planning is Bob Albanese, Senior Vice President of Strategic Development of CSM. Hailee Hunt-Hawkins, Study Coordinator at Vanderbilt Kennedy Center, will discuss the clinical site’s challenges faced as well as patient benefits. 

Webinar: Discover How Direct-to-Patient Shipping is Changing Clinical Trials 

Speakers: 

Bob Albanese, Senior VP of Strategic Development, CSM 
Hailee Hunt-Hawkins, Study Coordinator, Vanderbilt Kennedy Center 

Who Should Attend: 

Clinical Operations 
Clinical Supply Chain and Logistics
Primary Investigators 
Clinical Trial Coordinators 
Chief Executive Officers 
Date: Wednesday, September 28, 2016 
Time: 2:00PM Eastern 

Register Now: http://bit.ly/2b9YuuS

 

Latest stories

Related stories

FDA Approval of AMVUTTRA for ATTR Amyloidosis

Alnylam Pharmaceuticals, Inc., a global leader in RNAi therapeutics,...

Rina-S Shows Promise in Advanced Ovarian Cancer

Genmab has reported encouraging findings from the Phase 2...

New Data Shows Gazyva’s Superiority in Lupus Nephritis

The New England Journal of Medicine has published detailed...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back